Seroquel Paragraph IV Certification Filed
This article was originally published in The Pink Sheet Daily
The first ANDA with a Paragraph IV certification for AstraZeneca's Seroquel (quetiapine) was filed Aug. 12, according to FDA's Oct. 4 updated list of filings
You may also be interested in...
Company will file an NDA for the SR formulation of quetiapine for schizophrenia in July.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.